PMS22 ADALIMUMAB, ETANERCEPT AND INFLIXIMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS-COST EFFECTIVENESS ANALYSIS IN POLISH SETTINGS
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66790-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)66790-3/fulltext
Title :
PMS22 ADALIMUMAB, ETANERCEPT AND INFLIXIMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS-COST EFFECTIVENESS ANALYSIS IN POLISH SETTINGS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66790-3&doi=10.1016/S1098-3015(10)66790-3
First page :
Section Title :
Open access? :
No
Section Order :
625